ArticleMaterials today. Bio2025

Tumor-homing exosomes enable targeted delivery of siRNA and isoimperatorin for overcoming BTK inhibitor resistance in DLBCL.

Ruowen Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.